Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aerie Pharmaceuticals Inc (NASDAQ:AERI)

18.14
Delayed Data
As of Jul 31
 +0.23 / +1.28%
Today’s Change
8.84
Today|||52-Week Range
35.89
-37.86%
Year-to-Date
No recent news for Aerie Pharmaceuticals Inc.

Today’s Trading

Previous close17.91
Today’s open17.87
Day’s range17.62 - 18.35
Volume293,674
Average volume (3 months)1,100,229
Market cap$455.3M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+68.65%
Earnings growth (this year)-74.90%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book15.34

Competitors

 Today’s
change
Today’s
% change
PFNXPfenex Inc0.000.00%
PACBPacific Biosciences ...+0.15+2.71%
CRISCuris Inc-0.06-1.88%
NDRMNeuroderm Ltd+0.41+2.21%
Data as of 4:02pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$0.00
Annual profit (last year)-$48.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Vicente J. Anido
President &
Chief Operating Officer
Thomas A. Mitro
Corporate headquarters
Bedminster, New Jersey

Forecasts